ALPS Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $460K | Buy |
|
|||||
|
2025
Q2 | $281K | Buy |
|
|||||
|
2025
Q1 | $336K | Buy |
|
|||||
|
2024
Q4 | $221K | Hold |
|
|||||
|
2024
Q3 | $326K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $343K | Sell |
|
|||||
|
2023
Q3 | $329K | Sell |
|
|||||
|
2023
Q2 | $305K | Buy |
|
|||||
|
2023
Q1 | $345K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $309K | Sell |
|
|||||
|
2022
Q1 | $369K | Sell |
|
|||||
|
2021
Q4 | $360K | Buy |
|
|||||
|
2021
Q3 | $341K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $220K | Sell |
|
|||||
|
2020
Q3 | $876K | Buy |
|
|||||
|
2020
Q2 | $967K | Buy |
|
|||||
|
2020
Q1 | $222K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $287K | Sell |
|
|||||
|
2019
Q1 | $396K | Sell |
|
|||||
|
2018
Q4 | $444K | Sell |
|
|||||
|
2018
Q3 | $501K | Sell |
|
|||||
|
2018
Q2 | $469K | Sell |
|
|||||
|
2018
Q1 | $571K | Buy |
|
|||||
|
2017
Q4 | $508K | Buy |
|
|||||
|
2017
Q3 | $473K | Sell |
|
|||||
|
2017
Q2 | $691K | Buy |
|
|||||
|
2017
Q1 | $493K | Buy |
|
|||||
|
2016
Q4 | $399K | Buy |
|
|||||
|
2016
Q3 | $433K | Sell |
|
|||||
|
2016
Q2 | $378K | Sell |
|
|||||
|
2016
Q1 | $418K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $594K | Sell |
|
|||||
|
2014
Q3 | $594K | Sell |
|
|||||
|
2014
Q2 | $516K | Buy |
|
|||||
|
2014
Q1 | $534K | Buy |
|
|||||
|
2013
Q4 | $456K | Buy |
|
|||||
|
2013
Q3 | $253K | Buy |
|